ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,525.79
      1.64%
      US Tech 100
      18,796.80
      2.71%
      Dow Jones
      40,981.25
      0.58%
      Brent Oil
      80.435
      2.38%
      Bitcoin
      66,556.17
      0.58%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG

      6. Stantec Inc (S3A) Quote

      Stantec Inc

      Stantec Inc (S3A)

      TG
      79.00
      0.00
      ( 0.00% )
      Updated: 11:36:41
      Realtime Data

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      79.00
      Bid
      80.00
      Ask
      80.50
      Volume
      0.00
      0.00 Day's Range 0.00
      72.50 52 Week Range 81.50
      Previous Close
      79.00
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      38
      Financial Volume
      -
      VWAP
      -

      S3A Latest News

      More News

      Fennec Pharmaceuticals Announces Management Change

      RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that...

      July 01 2024
      GlobeNewswire Inc.

      Fennec Announces Results of Annual Meeting

      RESEARCH TRIANGLE PARK, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management...

      June 25 2024
      GlobeNewswire Inc.

      Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

      ~ Achieved First Quarter 2024 Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction ~ ~ Executed Exclusive Licensing...

      May 14 2024
      GlobeNewswire Inc.

      Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024

      RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...

      May 07 2024
      GlobeNewswire Inc.

      Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update

      ~ Achieved PEDMARK® Full-Year 2023 Net Product Sales of $21.3 Million, Including $9.7 Million in Net Product Sales in the Fourth Quarter of 2023 ~ ~ Entered Into Exclusive Licensing Agreement to...

      March 21 2024
      GlobeNewswire Inc.

      Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024

      RESEARCH TRIANGLE PARK, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that...

      March 19 2024
      GlobeNewswire Inc.

      Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

      Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand PR Newswire RESEARCH TRIANGLE PARK, N.C. and UXBRIDGE...

      March 18 2024
      PR Newswire (US)

      Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

      Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI®, the first and only approved therapy in the European Union and U.K. for reducing the risk of...

      March 17 2024
      GlobeNewswire Inc.

      Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

      ~ Fourth Quarter 2023 Net Revenues of Approximately $9.2 to $9.7 Million ~ ~ Company Expects to Report 2023 Fourth Quarter and Audited Full-Year Results on or about March 26, 2024 ~ RESEARCH...

      February 29 2024
      GlobeNewswire Inc.

      FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin

      RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that...

      February 01 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.5-0.6289308176179.58079.54979.79591837DE
      4-2.5-3.0674846625881.581.5785279.9375DE
      124.56.0402684563874.581.572.53877.61967695DE
      264.56.0402684563874.581.572.53977.11324042DE
      524.56.0402684563874.581.572.53977.11324042DE
      1564.56.0402684563874.581.572.53977.11324042DE
      2604.56.0402684563874.581.572.53977.11324042DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      9S70Critical Resources Limited
      0.006 €
      (50.00%)
      		166.67k
      BDDConico Ltd
      0.0008 €
      (33.33%)
      		125k
      PW2Powell Industries, Inc.
      161.20 €
      (30.74%)
      		611
      OY4Mogotes Metals Inc
      0.111 €
      (30.13%)
      		798.11k
      0LSBurgerFi International Inc
      0.65 €
      (30.00%)
      		40.52k
      CBOImunon Inc
      1.43 €
      (-53.27%)
      		53.75k
      1FGFibroGen Inc
      0.4858 €
      (-49.27%)
      		73.21k
      HHHAHomes & Holiday AG
      0.07 €
      (-48.15%)
      		240
      EJ7Energy Resources of Australia
      0.009 €
      (-35.72%)
      		252k
      T0UTC BioPharm Holdings plc
      0.55 €
      (-35.67%)
      		38.72k
      D7GNel ASA
      0.509 €
      (-1.36%)
      		2.18M
      DMLSayona Mining Limited
      0.019 €
      (3.83%)
      		1.07M
      LHADeutsche Lufthansa AG
      5.77 €
      (-2.30%)
      		1.06M
      NVDNVIDIA Corp
      107.14 €
      (11.90%)
      		804.31k
      OY4Mogotes Metals Inc
      0.111 €
      (30.13%)
      		798.11k

      Discussion

      View Full Feed
      Tomorrowneverknows Tomorrowneverknows 2 minutes ago
      Exactly
      HIRU
      wakeupdummy wakeupdummy 3 minutes ago
      they got another good quote.....
      "we're all sickypoo and it may be another week"
      i for one am sending over some chicken soup.
      IDVV
      luckydude777 luckydude777 3 minutes ago
      Nice alert. Thanks.
      Ms Labonte Ms Labonte 3 minutes ago
      $lap my a$$ and cal me $weet$$$ I love you $weet$$
      LAP WEET
      ANTI-BAGHOLDER ANTI-BAGHOLDER 3 minutes ago
      lol I figured you wouldn’t do it. All this talk and nothing…
      MONI
      bb8675309 bb8675309 3 minutes ago
      Nice post bas - A Comparison of the ADAS-Cog Scores for Aducanumab, Blarcamesine, Donanemab and Lecanemab!
      2024 07/30 👏

      Conclusions
      Clearly, from this chart Blarcamesine has substantially better performance than the other drugs. The Blarcamesine trial had no incl
      AVXL
      stealofadeal stealofadeal 3 minutes ago
      $GEVI Great entry price today and some are getting scooped up now.
      GEVI
      Monksdream Monksdream 3 minutes ago
      SYTA new 52 week low
      https://investorshub.advfn.com/uimage/uploads/2024/7/31/dcopfIMG_0177.gif
      SYTA
      3331 3331 3 minutes ago
      Bioelectronics (BIEL) - NEW CONTRACT - ready for blast off, CEO says "there is an agreement that requires our silence. That is all I can say".
      1) Golden Cross and Blue Skies Breakout Imminent! The 50 dma is .0001, 200 dma is .0002, yearly high is .0005.
      2) Profitabity: BIEL has cut
      Nebuchadnezzar Nebuchadnezzar 3 minutes ago
      will nibble at .0025

      fyi AMC is going to go nuts on friday
      HIRU
      redspeed redspeed 3 minutes ago
      I have calls in the afternoon. You can asked them for me.

      Also if there is time, ask them why they use Google for searching😂
      MONI
      ScottishTexan ScottishTexan 3 minutes ago
      Looks like you were right and I stand corrected. I am not a basher nor a pumper. Just a small retail player trying to make a buck. GLTA.
      IGPK
      WilliamMunny WilliamMunny 4 minutes ago
      In December of last year Anavex got approval to use the centralized procedure. There are no submissions taken for Rapporteur appointment in the month of December (and it would have been too late anyway at that point). Perhaps because of the scant time and end of year issues, they didn't hit the ea
      AVXL
      goldbarren58 goldbarren58 4 minutes ago
      feel screwed again yet?
      NWPN
      ANTI-BAGHOLDER ANTI-BAGHOLDER 4 minutes ago
      I told you. There is going to be around 200+ million sold.
      SINC
      stealofadeal stealofadeal 4 minutes ago
      $GEVI This stock trades unlike some.
      GEVI
      bar1080 bar1080 4 minutes ago
      Boeing names Ortberg to replace Calhoun as BA CEO

      https://www.bloomberg.com/news/articles/2024-07-31/boeing-names-kelly-ortberg-ceo-to-succeed-dave-calhoun
      PonkenPlonken PonkenPlonken 4 minutes ago
      MLGO 1.57 lets see if they game it lower prior to a real move
      MLGO
      ANTI-BAGHOLDER ANTI-BAGHOLDER 4 minutes ago
      I see a real big opportunity here.
      MONI
      236T568 236T568 5 minutes ago
      NBC News falling deeper in the hole

      dissapointed
      OzzyS85 OzzyS85 5 minutes ago
      I just got my 40 virgins. More coming st .0031.
      Weeeeeeeeeee
      HIRU
      stink stack stink stack 5 minutes ago
      Smile, I see GREEN!
      FMCC

      Your Recent History

      TG
      S3A
      Stantec
      Delayed Upgrade Clock